Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2214PDF: 1744HTML: 559 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2956PDF: 1391HTML: 3635Untitled: 203Untitled: 217Untitled: 191 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
834PDF: 113HTML: 166 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
530PDF: 262HTML: 104 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1093PDF: 1197Suppl. Files: 576HTML: 94 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1301PDF: 1093HTML: 228 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1432HTML: 545PDF: 854 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3868PDF: 1700HTML: 11707Figures Haase: 221 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2036PDF: 746HTML: 701Table1: patient's characteristics: 163Table 2: profile of each patient: 188 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3408PDF: 2000HTML: 7519 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2517HTML: 293PDF: 921 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3610PDF: 1251HTML: 5042Incidence age-standardized rates for HL across the Mediterranean basin: 221 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3318PDF: 1733HTML: 1120 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2634PDF: 820HTML: 5289 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9226PDF: 6143HTML: 88013Fig.1b: 199Fig.1c: 207Fig.2a: 194Fig.2b: 191Fig.4: 209Fig.2c: 194Fig.3: 197Tab.1: 247Tab.2: 221Tab.3: 207Tab.4: 241Fig1a: 203 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1613PDF: 1068HTML: 314 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3645PDF: 2560HTML: 1534 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3719PDF: 915HTML: 6775 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2781PDF: 1038HTML: 208Suppl. Files: 525 -
SOLITARY PLASMACYTOMA
3995PDF: 2229HTML: 1292fIGURES 1,2: 236 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3116PDF: 891HTML: 7219Kost Fig1: 202Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 205Kost Fig5: 204Kost fig 6: 189 -
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
3701PDF: 1695HTML: 2685 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2230PDF: 1640HTML: 360 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2521PDF: 804HTML: 1743 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4069PDF: 1564HTML: 9214Untitled: 288Untitled: 195Untitled: 181Untitled: 173Untitled: 197Untitled: 352 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2827PDF: 1149HTML: 3300 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4039PDF: 1071HTML: 3720Untitled: 182Cneo. Fig.1: 117Untitled: 111Untitled: 137Untitled: 143 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2874PDF: 1036HTML: 5568 -
-
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4226PDF: 1966HTML: 5400Table 1: 220







